Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RVLT
5951
PUT
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
| $28K | ﹤0.01% |
+1,110
| New | +$40.3K |
2013 Q3
0 quarters
|
|
|
BALT
5952
CALL
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $28K | ﹤0.01% |
+5,800
| New | +$25.3K |
2013 Q3
0 quarters
|
|
|
RNA
5953
PUT
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $28K | ﹤0.01% |
+4,300
| New | +$101K |
2013 Q3
0 quarters
|
|
|
VSB
5954
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
| $28K | ﹤0.01% |
+5,195
| New | +$26.8K |
2013 Q3
0 quarters
|
|
|
MCP.PRA
5955
DELISTED
MOLYCORP, INC PFD CONV SER A
MCP.PRA
| $28K | ﹤0.01% |
1,363
+1,240
| +1,008% | +$27.8K |
2013 Q2
1 quarter
|
|
5956
CALL
Benchmark Electronics
BHE
$3.14B
| $27K | ﹤0.01% |
1,200
-1,600
| -57% | -$35.4K |
2013 Q2
1 quarter
|
|
5957
CALL
Emcor
EME
$34.7B
| $27K | ﹤0.01% |
700
-4,200
| -86% | -$170K |
2013 Q2
1 quarter
|
|
|
MASI
5958
PUT
DELISTED
Masimo
MASI
| $27K | ﹤0.01% |
1,000
-1,800
| -64% | -$44.4K |
2013 Q2
1 quarter
|
|
5959
CALL
MKS Inc
MKSI
$18.9B
| $27K | ﹤0.01% |
1,000
-200
| -17% | -$5.34K |
2013 Q2
1 quarter
|
|
5960
CALL
TTM Technologies
TTMI
$13.9B
| $27K | ﹤0.01% |
2,800
-1,300
| -32% | -$12.4K |
2013 Q2
1 quarter
|
|
|
ENZ
5961
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
| $27K | ﹤0.01% |
10,800
+100
| +0.9% | +$237 |
2013 Q2
1 quarter
|
|
|
ENLC
5962
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $27K | ﹤0.01% |
1,300
-1,600
| -55% | -$32.4K |
2013 Q2
1 quarter
|
|
|
GMO
5963
DELISTED
General Moly, Inc.
GMO
| $27K | ﹤0.01% |
16,134
-82,468
| -84% | -$149K |
2013 Q2
1 quarter
|
|
|
BMS
5964
CALL
DELISTED
Bemis
BMS
| $27K | ﹤0.01% |
700
-3,400
| -83% | -$138K |
2013 Q2
1 quarter
|
|
|
FNFG
5965
PUT
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $27K | ﹤0.01% |
2,600
+100
| +4% | +$1.04K |
2013 Q2
1 quarter
|
|
|
BALT
5966
PUT
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
| $27K | ﹤0.01% |
+5,600
| New | +$24.4K |
2013 Q3
0 quarters
|
|
|
BPZ
5967
PUT
DELISTED
BPZ RESOURCES INC COM STK
BPZ
| $27K | ﹤0.01% |
13,600
-32,400
| -70% | -$72.8K |
2013 Q2
1 quarter
|
|
|
CADX
5968
PUT
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
| $27K | ﹤0.01% |
4,200
-3,900
| -48% | -$24.8K |
2013 Q2
1 quarter
|
|
|
WRES
5969
PUT
DELISTED
WARREN RESOURCES INC
WRES
| $27K | ﹤0.01% |
9,300
-2,900
| -24% | -$8.42K |
2013 Q2
1 quarter
|
|
5970
CALL
American Superconductor
AMSC
$1.45B
| $26K | ﹤0.01% |
1,100
+60
| +6% | +$1.52K |
2013 Q2
1 quarter
|
|
5971
PUT
Anika Therapeutics
ANIK
$256M
| $26K | ﹤0.01% |
+1,100
| New | +$24.7K |
2013 Q3
0 quarters
|
|
5972
CALL
AXIS Capital
AXS
$6.92B
| $26K | ﹤0.01% |
600
| – | – |
2013 Q2
1 quarter
|
|
5973
PUT
Bloomin' Brands
BLMN
$726M
| $26K | ﹤0.01% |
1,100
-1,700
| -61% | -$40.7K |
2013 Q2
1 quarter
|
|
5974
Century Aluminum
CENX
$3.53B
| $26K | ﹤0.01% |
3,209
+1,958
| +157% | +$17.3K |
2013 Q2
1 quarter
|
|
|
DVAX
5975
DELISTED
Dynavax Technologies
DVAX
| $26K | ﹤0.01% |
2,176
+385
| +21% | +$4.84K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.